PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Medicine, Division of General Internal Medicine and Geriatrics, Section of Addiction Medicine, Oregon Health & Science University, Portland, OR, USA.\', \'Department of Medicine, Johns Hopkins School of Medicine, Baltimore, MD, USA.\', \'Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, MD, USA.\', \'Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1080/08897077.2021.1986768
?:doi
?:hasPublicationType
?:journal
  • Substance abuse
is ?:pmid of
?:pmid
?:pmid
  • 34666636
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.009
?:rankingScore_hIndex
  • 36
is ?:relation_isRelatedTo_publication of
?:title
  • COVID-19-related policy changes for methadone take-home dosing: A multistate survey of opioid treatment program leadership.
?:type
?:year
  • 2022

Metadata

Anon_0  
expand all